Atlassian's 35% Friday Surge Puts a $4.8 Billion Backlog Against a Sharply Slower Growth Forecast
Published on 08/10/2026 at 06:14 | Redaktion boerse-global.de
The obituary for traditional software-as-a-service companies was written early this year. The thesis, repeated across trading desks and conference calls, held that generative AI would let enterprises build their own internal tools with a few well-crafted prompts, rendering subscription platforms like Atlassian's redundant. On Thursday, the company's fiscal fourth-quarter results delivered a pointed rebuttal — and the market responded with one of the most violent upside moves in the stock's recent history.
Shares closed Friday at €128.80, up 34.87% in a single session. The rally was fueled by revenue of $1.766 billion for the quarter ended June 30, up 28% year over year, alongside cloud revenue growth of 31% to $1.213 billion. Non-GAAP earnings per share of $1.87 came in ahead of analyst expectations. But the figure that most captured Wall Street's attention was the remaining performance obligations (RPO) balance, which jumped 44% to $4.817 billion — evidence that customers are signing longer and larger commitments rather than trimming their software budgets.
A CEO Putting Money Where the Guidance Is
The earnings release was accompanied by a notable signal from the top. Co-founder and CEO Mike Cannon-Brookes disclosed plans to purchase up to $250 million of Atlassian stock in the open market through a Rule 10b5-1 trading plan — a gesture that investors typically interpret as a statement of conviction from someone with the clearest view of the company's trajectory. Management also announced the appointment of Ken Exner as Chief Product Officer for Enterprise and Emerging, bringing more than three decades of experience, including a stint as one of AWS's first 40 employees and a recent role at Elastic where he helped double ARR to nearly $2 billion.
The timing of the insider buying is notable given what preceded the report. In the week before the earnings release, the stock had fallen 5.5% on concerns about the forward revenue outlook. That anxiety was not unfounded: Atlassian's own projections for fiscal 2027 call for total revenue growth of roughly 13%, a sharp deceleration from the 28% pace just reported. The company guided first-quarter revenue to $1.705–$1.715 billion, with cloud growth of approximately 28.5% and a 4.0% decline in the legacy data-center business, which is being phased out entirely by 2029.
Should investors sell immediately? Or is it worth buying Atlassian?
The Enterprise Engine Shows No Signs of Stalling
What gives bulls confidence that the slowdown is a managed transition rather than a structural problem is the momentum in the company's largest accounts. Atlassian reported a record quarter for deals exceeding $1 million, $3 million, and $5 million in annual contract value. The cohort of customers with ARR above $3 million grew by more than 50%, while those above $5 million expanded by over 70%. The company also signed the largest single contract in its history with one of the world's biggest technology conglomerates.
Product development is tracking the enterprise push. New agent-based capabilities in Jira allow development teams to delegate work to AI agents and measure their costs against output. The company's Rovo AI assistant has achieved HIPAA compliance, opening the door to regulated industries such as healthcare, while the forthcoming "Isolated Cloud" offering targets organizations with strict data-residency requirements. Management noted that monthly usage of its MCP server and Teamwork Graph CLI more than doubled within a single quarter, crossing the million-user threshold. A Leader placement in the Gartner Magic Quadrant for developer-productivity platforms adds further validation.
The analyst community has largely swung behind the story. Morgan Stanley initiated coverage Friday with an Overweight rating and a price target of $120, arguing that Atlassian is more likely to benefit from AI than to suffer from it. Jefferies went further, setting a target of $200 and pointing to the accelerated RPO growth and a valuation that remains reasonable relative to peers; the firm also noted that Rovo usage rose 50% quarter over quarter. Other houses adjusted targets across a range of $115 to $200, though not all revisions were upward — KeyBanc trimmed its target from $130 to $115 while maintaining an Overweight stance, suggesting the fiscal 2027 outlook may be deliberately conservative.
A Rally That Still Leaves Ground to Recover
For all the enthusiasm, the stock's recent run has been extraordinary by any measure. The shares have gained 65.55% over the past 30 days and 42.79% over the past week. Yet even after Friday's surge, the stock remains 7.43% below its level at the start of the year — a reminder that a single quarter has not fully erased the damage from a difficult first half. The 52-week high of €158.16, set in September 2025, sits 18.56% above the current price.
Atlassian at a turning point? This analysis reveals what investors need to know now.
The central question for the coming quarters is whether cloud growth of roughly 28.5% can more than offset the planned wind-down of the data-center business. The operating margin trajectory offers a clue to the cost of this transition: the company expects a non-GAAP margin of approximately 28.5% in the first quarter of fiscal 2027, well below the 36% achieved in the just-reported period. If the data-center decline accelerates beyond the guided 4.0% per quarter, or if cloud growth slips under the 28.5% threshold, the growth narrative would lose credibility quickly.
The next test comes with the fiscal first-quarter report, where investors will see whether management hits, beats, or merely confirms its own targets. Until then, Cannon-Brookes' planned share purchases give the market a tangible metric for gauging insider confidence — and a reason to believe that the man who built the company sees the current valuation as an opportunity rather than a peak.
Ad
Atlassian Stock: New Analysis - 10 August
Fresh Atlassian information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
